Search clinical trials for: Enfortumab vedotin
Total 406 results
-
University of Texas Southwestern Medical CenterAstellas Pharma IncNot yet recruiting
-
University of Michigan Rogel Cancer CenterNot yet recruitingUrothelial CarcinomaUnited States
-
National Cancer Institute (NCI)Not yet recruitingAdvanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm
-
Giuseppe ProcopioNot yet recruitingCollecting Duct Carcinoma | Renal Medullary Carcinoma | Bellini CarcinomaItaly
-
Mayo ClinicRecruitingStage IV Penile Cancer AJCC v8 | Stage III Penile Cancer AJCC v8 | Metastatic Penile Squamous Cell Carcinoma | Unresectable Penile Squamous Cell CarcinomaUnited States
-
National Cancer Institute (NCI)Not yet recruitingAdenocarcinoma of the Bladder | Squamous Cell Carcinoma of the Bladder | Testicular Germ Cell TumorsUnited States
-
Astellas Pharma Korea, Inc.Seagen Inc.RecruitingUrothelial CancerKorea, Republic of
-
Fox Chase Cancer CenterRecruitingUrothelial Carcinoma | Metastatic Urothelial Carcinoma | Locally Advanced Urothelial CarcinomaUnited States
-
University of Kansas Medical CenterRecruitingPancreas Adenocarcinoma | Pancreatic Ductal Adenocarcinoma | Pancreas CancerUnited States
-
Kyoto University HospitalMerck Sharp & Dohme LLC; Astellas Pharma Inc; University of Tsukuba; Kobe City... and other collaboratorsRecruiting
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma US, Inc.RecruitingUrothelial CarcinomaUnited States
-
Jonsson Comprehensive Cancer CenterMerck Sharp & Dohme LLC; Seagen Inc.Not yet recruitingRenal Pelvis and Ureter Urothelial CarcinomaUnited States
-
Emory UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; Astellas Pharma Inc; Seagen...RecruitingStage III Bladder Cancer AJCC v8 | Stage IV Bladder Cancer AJCC v8 | Bladder Adenocarcinoma | Bladder Squamous Cell Carcinoma | Metastatic Bladder Carcinoma | Urachal Adenocarcinoma | Locally Advanced Bladder Carcinoma | Malignant Renal Pelvis Neoplasm | Malignant Ureter Neoplasm | Malignant Urethral Neoplasm and other conditionsUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Merck Sharp & Dohme LLC; Astellas Pharma Inc; Seagen Inc.Not yet recruitingBladder Cancer | Urothelial Carcinoma Bladder | High Grade Urothelial CarcinomaUnited States
-
ALX Oncology Inc.RecruitingBladder Cancer | Urothelial CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLC; Astellas Pharma US, Inc.; Seagen Inc.RecruitingUrothelial CarcinomaUnited States
-
Astellas Pharma Global Development, Inc.Seagen Inc.RecruitingCarcinoma in Situ | Urinary Bladder Neoplasms | Non-muscle Invasive Bladder Cancer | Carcinoma Transitional Cell | NMIBCUnited States, Canada, France, Spain, United Kingdom, Germany
-
National Cancer Institute (NCI)RecruitingMetastatic Bladder Urothelial Carcinoma | Metastatic Renal Pelvis Urothelial Carcinoma | Metastatic Ureter Urothelial Carcinoma | Metastatic Urethral Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Recurrent Bladder Urothelial Carcinoma | Recurrent Renal Pelvis Urothelial Carcinoma | Recurrent... and other conditionsUnited States
-
AstraZenecaRecruitingMuscle Invasive Bladder CancerNetherlands, United Kingdom, Korea, Republic of, Canada, Germany, Italy, Poland, Spain, Turkey, Vietnam, Argentina, Japan, France, Brazil, Taiwan, United States, Israel, Austria, Chile, Colombia, Greece, Hong Kong, Mexico, Portugal, Russian... and more
-
Emory UniversityNational Cancer Institute (NCI); ExelixisRecruitingMetastatic Urothelial Carcinoma | Locally Advanced Urothelial Carcinoma | Unresectable Urothelial Carcinoma | Infiltrating Bladder Urothelial Carcinoma With Squamous DifferentiationUnited States
-
University of UtahAstellas Pharma IncRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLC; Seagen Inc.RecruitingLocally Advanced or Metastatic Malignant Solid TumorsUnited States, Japan, Canada
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLC; Seagen Inc.RecruitingUrothelial CancerUnited States, Argentina, Australia, Belgium, Canada, China, Czechia, Denmark, France, Germany, Hungary, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Russian Federation, Singapore, Spain, Switzerland, Taiwan, Thailand and more
-
Hoffmann-La RocheGilead Sciences, Inc., GlaxoSmithKline plc, Seattle Genetics and AstellasRecruitingBladder Cancer | Urothelial CarcinomaUnited States, Spain, Korea, Republic of, United Kingdom, Taiwan, France, Greece
-
Astellas Pharma China, Inc.Seagen Inc.Active, not recruitingMetastatic Urothelial CancerChina
-
Merck Sharp & Dohme LLCSeagen Inc.; Astellas Pharma Global Development, Inc.Active, not recruitingUrinary Bladder Cancer, Muscle-invasiveCanada, United States, Australia, Belgium, France, Hungary, Italy, Korea, Republic of, Mexico, Poland, Russian Federation, Thailand, Ukraine, Argentina, Colombia, Denmark, Germany, Ireland, Israel, Japan, Malaysia, Philippines, Sing... and more
-
Mirati Therapeutics Inc.Active, not recruitingAdvanced or Metastatic Solid MalignanciesUnited States
-
Astellas Pharma Global Development, Inc.Seagen Inc.Active, not recruitingBladder Cancer | Urothelial Cancer | Ureteral CancerUnited States, Japan, Korea, Republic of, Taiwan, Argentina, Australia, Austria, Belgium, Canada, Denmark, France, Germany, Italy, Netherlands, Portugal, Russian Federation, Spain, Switzerland, United Kingdom
-
Merck Sharp & Dohme LLCActive, not recruitingMetastatic Urothelial Carcinoma | Urothelial NeoplasmsAustralia, United States, Canada, Chile, France, Israel, Italy, Korea, Republic of, Netherlands, Spain, Taiwan, United Kingdom
-
Merck Sharp & Dohme LLCAstellas Pharma Inc; Seagen Inc.Active, not recruitingBladder CancerHungary, United States, China, Argentina, Australia, Bulgaria, Canada, Colombia, Croatia, Czechia, France, Germany, Greece, Israel, Italy, Japan, Korea, Republic of, Malaysia, Philippines, Poland, Portugal, Romania, Russian Federation, Singapo... and more
-
Astellas Pharma Global Development, Inc.Seagen Inc.CompletedMetastatic Urothelial Cancer and Other Malignant Solid TumorsUnited States, Canada
-
Dana-Farber Cancer InstituteGilead SciencesActive, not recruitingBladder Cancer | Urothelial Cancer | Metastatic Urothelial Carcinoma | Metastatic Urothelial Carcinoma of the Renal Pelvis and UreterUnited States
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLC; Seagen Inc.Active, not recruitingUrologic Neoplasms | Urinary Bladder Neoplasms | Carcinoma, Transitional Cell | Ureteral Neoplasms | Urothelial Cancer | Urethral Neoplasms | Renal Pelvis NeoplasmsUnited States, Italy, Spain, Canada, France, Puerto Rico
-
Astellas Pharma IncSeagen Inc.CompletedUrologic Neoplasms | Urinary Bladder Neoplasms | Carcinoma, Transitional Cell | Ureteral Neoplasms | Urothelial Cancer | Urethral Neoplasms | Renal Pelvis NeoplasmsUnited States, Korea, Republic of, Spain, France, Germany, Italy, Japan, Netherlands
-
Mirati Therapeutics Inc.TerminatedUrothelial Carcinoma Bladder | Urothelial Carcinoma | Urothelial Carcinoma Ureter | Urothelial Carcinoma of the Renal Pelvis and Ureter | Urothelial Carcinoma UrethraUnited States
-
ShireCompletedHereditary Angioedema (HAE)United States, Jordan, Canada
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI); Southwest Oncology Group; North Central Cancer...CompletedBreast Cancer | OsteoporosisCanada
-
Astellas Pharma IncSeagen Inc.CompletedMetastatic Urothelial CancerJapan
-
Astellas Pharma Global Development, Inc.Seagen Inc.Approved for marketingLocally Advanced or Metastatic Urothelial Carcinoma (UC)United States
-
MerLion Pharmaceuticals GmbHCompleted
-
Bernstein, Jonathan A., M.D.Dyax Corp.Unknown
-
Chinese PLA General HospitalNot yet recruitingPD-1 Inhibitor Failed Patients With Classical Hodgkin Lymphoma
-
Merck Sharp & Dohme LLCNot yet recruitingBurkitt Lymphoma | Ewing Sarcoma | Neuroblastoma | Diffuse Large B-cell Lymphoma | B-cell Acute Lymphoblastic Leukemia
-
RemeGen Co., Ltd.Not yet recruiting
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingGastric Cancer/Gastroesophageal Junction Adenocarcinoma
-
Zhejiang Cancer HospitalRecruitingHER2 Gene Mutation | Bile Duct Adenocarcinoma Non-ResectableChina
-
RemeGen Co., Ltd.Not yet recruitingHigh-risk Non-muscle Invasive Bladder CancerChina
-
Memorial Sloan Kettering Cancer CenterSeagen Inc.Recruiting
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingFirst-line Treatment | HER2-positive Metastatic Breast CancerChina
-
Seagen Inc.RecruitingLymphoma, Large B-Cell, Diffuse | Hodgkin Disease | Lymphoma, T-Cell, Peripheral | Lymphoma, Large-Cell, AnaplasticUnited States